Literature DB >> 8226103

Electron microscopic immunocytochemical demonstration of blood-retinal barrier breakdown in human diabetics and its association with aldose reductase in retinal vascular endothelium and retinal pigment epithelium.

S A Vinores1, E Van Niel, J L Swerdloff, P A Campochiaro.   

Abstract

Light-microscopic immunohistochemical staining for albumin has been used to localize sites of blood-retinal barrier (BRB) breakdown in ocular disorders, but the mechanism for BRB compromise cannot be resolved at this level. Using eyes up to 2 days post-mortem from normal patients or from patients with diabetic retinopathy, or other disorders known to cause BRB failure, electron-microscopic immunocytochemistry reveals focal breakdown of the inner BRB, comprised of the retinal vascular endothelium (RVE), which appears to be mediated by diffuse permeation of the RVE cells and by vesicular transport. Permeation of the retinal pigmented epithelial (RPE) cells that comprise the outer BRB also occurs, but there is no evidence of opening of tight junctions between RVE or RPE in any of the disorders evaluated. Increased aldose reductase (AR) expression in the RVE and RPE cells of diabetics as well as in the perivascular retinal astrocytes, which interact with RVE cells to establish the inner BRB, suggests that AR activity and the subsequent intracellular accumulation of sorbitol in these cell types may impair the function of the BRB in diabetes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226103     DOI: 10.1007/bf00157879

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  48 in total

1.  Induction of blood-brain barrier characteristics in bovine brain endothelial cells by rat astroglial cells in transfilter coculture.

Authors:  J Neuhaus; W Risau; H Wolburg
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

2.  Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors.

Authors:  P F Kador; Y Akagi; Y Takahashi; H Ikebe; M Wyman; J H Kinoshita
Journal:  Arch Ophthalmol       Date:  1990-09

3.  Tight junctions of brain endothelium in vitro are enhanced by astroglia.

Authors:  J H Tao-Cheng; Z Nagy; M W Brightman
Journal:  J Neurosci       Date:  1987-10       Impact factor: 6.167

Review 4.  The sorbitol pathway and the complications of diabetes.

Authors:  K H Gabbay
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

5.  An electron microscopical demonstration of the permeability of cerebral and retinal capillaries to ions.

Authors:  J R Casley-Smith
Journal:  Experientia       Date:  1969-08-15

Review 6.  The structure and function of the blood-brain barrier.

Authors:  M W Bradbury
Journal:  Fed Proc       Date:  1984-02

7.  Studies on the permeability of the blood-retinal barrier. IV. Junctional complexes of the retinal vessels and their role in the permeability of the blood-retinal barrier.

Authors:  M Shakib; J G Cunha-Vaz
Journal:  Exp Eye Res       Date:  1966-07       Impact factor: 3.467

8.  Prevention or moderation of some ultrastructural changes in the RPE and retina of galactosemic rats by aldose reductase inhibition.

Authors:  S A Vinores; P A Campochiaro
Journal:  Exp Eye Res       Date:  1989-09       Impact factor: 3.467

9.  Effect of sulindac on the permeability of the blood-retinal barrier in early diabetic retinopathy.

Authors:  J G Cunha-Vaz; C C Mota; E C Leite; J R Abreu; M A Ruas
Journal:  Arch Ophthalmol       Date:  1985-09

10.  Vitreous fluorophotometry in the alloxan- and streptozocin-treated rat.

Authors:  C W Jones; J G Cunha-Vaz; M M Rusin
Journal:  Arch Ophthalmol       Date:  1982-07
View more
  12 in total

Review 1.  Macular oedema: the role of soluble mediators.

Authors:  D Kent; S A Vinores; P A Campochiaro
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

2.  Consumption of polyphenol-rich Morus alba leaves extract attenuates early diabetic retinopathy: the underlying mechanism.

Authors:  Ayman M Mahmoud; Sanaa M Abd El-Twab; Eman S Abdel-Reheim
Journal:  Eur J Nutr       Date:  2016-04-08       Impact factor: 5.614

Review 3.  Diabetic retinopathy: Breaking the barrier.

Authors:  Randa S Eshaq; Alaa M Z Aldalati; J Steven Alexander; Norman R Harris
Journal:  Pathophysiology       Date:  2017-07-12

4.  RPE barrier breakdown in diabetic retinopathy: seeing is believing.

Authors:  Hui-Zhuo Xu; Zhiming Song; Shuhua Fu; Meili Zhu; Yun-Zheng Le
Journal:  J Ocul Biol Dis Infor       Date:  2011-12-31

Review 5.  Dietary hyperglycemia, glycemic index and metabolic retinal diseases.

Authors:  Chung-Jung Chiu; Allen Taylor
Journal:  Prog Retin Eye Res       Date:  2010-09-22       Impact factor: 21.198

Review 6.  Cellular mechanisms of blood-retinal barrier dysfunction in macular edema.

Authors:  S A Vinores; N L Derevjanik; H Ozaki; N Okamoto; P A Campochiaro
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

7.  TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis.

Authors:  Hu Huang; Jarel K Gandhi; Xiufeng Zhong; Yanhong Wei; Junsong Gong; Elia J Duh; Stanley A Vinores
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-10       Impact factor: 4.799

8.  QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY REVEALS ROD PHOTORECEPTOR DEGENERATION in EARLY DIABETIC RETINOPATHY.

Authors:  David Le; Taeyoon Son; Jennifer I Lim; Xincheng Yao
Journal:  Retina       Date:  2022-08-01       Impact factor: 3.975

9.  Osmotic expression of aldose reductase in retinal pigment epithelial cells: involvement of NFAT5.

Authors:  Anica Winges; Tarcyane Barata Garcia; Philipp Prager; Peter Wiedemann; Leon Kohen; Andreas Bringmann; Margrit Hollborn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-09-14       Impact factor: 3.117

10.  The fast oscillation of the EOG in diabetes with and without mild retinopathy.

Authors:  Marilyn E Schneck; Leslie Shupenko; Anthony J Adams
Journal:  Doc Ophthalmol       Date:  2007-10-25       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.